“We provide holistic commercialization services by working with clients throughout a product’s life cycle from early-stage strategic planning and launch, to post-launch marketing support,” says Tim Disher, senior director, biostatistics, value & evidence, EVERSANA. “Our goal is to ensure patients have timely access to effective treatments by helping out clients to bring therapies and technologies to the market.”
Most important, EVERSANA eliminates pharmaceutical companies’ need to engage with multiple vendors. They are the one-stop shop that can handle everything for clients working with a shared purpose and vision.
What enables EVERSANA to provide such comprehensive service is its team of seasoned HEOR researchers and industry experts, who are always focused on improving healthcare outcomes.
EVERSANA: Offering Superior Commercialization Support
The capable team has equipped EVERSANA with the capability to serve numerous global pharmaceutical companies. Many of the company’s clients, in fact, have been working with it for years now.
We provide holistic commercialization services by working with clients throughout a product’s life cycle from early-stage strategic planning and launch, to post-launch marketing support
EVERSANA’s indomitable fervor to drive clients through all the complexities allows it to continuously improve healthcare outcomes. The company understands that commercializing a new product in the market is no less than an uphill journey, requiring pharmaceutical companies to address the demand of different stakeholders, including regulators, patients, and payers. Given this situation, a partner like EVERSANA and specifically their best-in-class value & evidence solutions can really make a difference by supporting clients from pre-launch to post-launch.